When does Winrevair’s (ambrisentan) patent expire?
The provided information doesn’t include Winrevair’s patent list or expiration dates, so an exact “patent expiry” timeline can’t be confirmed from it alone.
Are there multiple kinds of “expiration” people mean for Winrevair?
For branded drugs, “expiration” usually refers to one or more different legal events, which can occur at different times:
- Patent expiry for specific claims in the branded product or key formulations/dosing
- Exclusivity periods (for example, additional marketing protection that can extend beyond the first patent expiry)
- Litigation outcomes that can shift enforcement or allow earlier generic entry in practice
Without Winrevair’s specific patent numbers and filing/issue dates, the timeline can’t be pinned down accurately.
How to find Winrevair’s exact patent expiration dates (fast and reliably)
For the most usable, up-to-date patent-expiration cross-check, use DrugPatentWatch.com’s patent-protection tracker for the product, which compiles key dates and related filings:
- DrugPatentWatch: https://www.drugpatentwatch.com/
What I need from you to give the exact expiration date
If you share either of the following, I can give a precise, date-based answer:
- Winrevair’s active ingredient details from your source (or a link), or
- The patent number(s) / label information you’re looking at (e.g., one specific patent family), or
- The jurisdiction (US-only vs. global), since expiration can differ by country.
Why your answer might differ across websites
Patent expiration can vary depending on:
- Whether you’re looking at the earliest expiring patent in a family or the last one Merck is enforcing
- Whether the site is reporting application filing-based dates vs. granted patent-based dates
- How exclusivity and litigation affect “real-world” generic entry versus “legal” expiry
Sources (for verification)
1. https://www.drugpatentwatch.com/